- Home
- HUCK vs RNA Comparison
HUCK vs RNA Comparison
Compare HUCK & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.11
SELL
Current Price
$7.73
Company Overview
Basic Information| Metric | HUCK | RNA |
|---|---|---|
| Founded | 2010 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.5M | 141.3M |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | HUCK | RNA |
|---|---|---|
| Price | $3.11 | $7.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $4.17 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 777.6K | 242.7K |
| Earning Date | 12-03-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.92 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $318,857,000.00 | N/A |
| Revenue This Year | N/A | $84.55 |
| Revenue Next Year | $1.33 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $2.98 | $7.54 |
| 52 Week High | $3.55 | $73.06 |
Technical Indicators
Market Signals| Indicator | HUCK | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 34.32 | 31.14 |
| Support Level | $3.00 | $7.63 |
| Resistance Level | $3.45 | $8.50 |
| Average True Range (ATR) | 0.13 | 0.33 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 29.47 | 25.52 |
Price Performance
Historical Comparison HUCK
RNA
About RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.